Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer

Fingerprint

Dive into the research topics of 'Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences